Xpert MTB/RIF Ultra: a gamechanger for tuberculous meningitis?

Affiliations

¹ Division of Medical Microbiology, Department of Pathology, Cape Town 7925, South Africa; University of Cape Town, Cape Town 7925, South Africa; National Health Laboratory Service, Cape Town, South Africa.
² Division of Medical Microbiology, Department of Pathology, Cape Town 7925, South Africa; Institute of Infectious Diseases and Molecular Medicine, Cape Town 7925, South Africa; University of Cape Town, Cape Town 7925, South Africa; National Health Laboratory Service, Cape Town, South Africa. Electronic address: mark.nicol@uct.ac.za.

Free article

Comment

Margaret Khonga et al. Lancet Infect Dis. 2018 Jan.

Free article

. 2018 Jan;18(1):6-8.

doi: 10.1016/S1473-3099(17)30536-4. Epub 2017 Sep 14.

¹ Division of Medical Microbiology, Department of Pathology, Cape Town 7925, South Africa; University of Cape Town, Cape Town 7925, South Africa; National Health Laboratory Service, Cape Town, South Africa.
² Division of Medical Microbiology, Department of Pathology, Cape Town 7925, South Africa; Institute of Infectious Diseases and Molecular Medicine, Cape Town 7925, South Africa; University of Cape Town, Cape Town 7925, South Africa; National Health Laboratory Service, Cape Town, South Africa. Electronic address: mark.nicol@uct.ac.za.

No abstract available

Comment on

Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study.
Bahr NC, Nuwagira E, Evans EE, Cresswell FV, Bystrom PV, Byamukama A, Bridge SC, Bangdiwala AS, Meya DB, Denkinger CM, Muzoora C, Boulware DR; ASTRO-CM Trial Team. Bahr NC, et al. Lancet Infect Dis. 2018 Jan;18(1):68-75. doi: 10.1016/S1473-3099(17)30474-7. Epub 2017 Sep 14. Lancet Infect Dis. 2018. PMID: 28919338 Free PMC article.